Literature DB >> 6181012

Characterization of cyclophosphamide-induced suppressor cells.

K R McIntosh, M Segre, D Segre.   

Abstract

Spleen cells from mice injected with cyclophosphamide (200 mg/kg body weight) suppress the secondary immunoglobulin (IgG antibody response of memory cells to a T-dependent antigen, dinitrolphenylated (DNP) human gamma globulin, in Millipore diffusion chambers. Characterization of the suppressor cell revealed that it was nylon wool nonadherent, insensitive to treatment with anti-Thy 1.2 or anti-Ig serum plus C, found in spleen but not thymus or lymph nodes, generated in thymectomized mice and nude mice, and heat-sensitive. Because of these unique characteristics, it was concluded that the suppressor cell was not a typical B cell, T cell, or macrophage. The suppressor cell was found to be regulated, i.e., inhibited, by a T cell found in the thymus and possibly the lymph nodes of normal mice. The suppressor cells may have biological significance in relation to development of self-tolerance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6181012     DOI: 10.1016/0162-3109(82)90049-2

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  10 in total

1.  Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulation.

Authors:  Zhi-Chun Ding; David H Munn; Gang Zhou
Journal:  Oncoimmunology       Date:  2014-08-03       Impact factor: 8.110

2.  Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axis.

Authors:  Zhi-Chun Ding; Xiaoyun Lu; Miao Yu; Henrique Lemos; Lei Huang; Phillip Chandler; Kebin Liu; Matthew Walters; Antoni Krasinski; Matthias Mack; Bruce R Blazar; Andrew L Mellor; David H Munn; Gang Zhou
Journal:  Cancer Res       Date:  2014-04-29       Impact factor: 12.701

Review 3.  Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T Cells.

Authors:  Michal Kuczma; Zhi-Chun Ding; Gang Zhou
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

4.  Cyclophosphamide treatment antagonizes the in vitro development of Mycobacterium lepraemurium-induced suppressor cell precursors.

Authors:  D Gosselin; R Turcotte; S Lemieux
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

5.  Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).

Authors:  D M Karussis; U Vourka-Karussis; D Lehmann; O Abramsky; A Ben-Nun; S Slavin
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

6.  Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan.

Authors:  A Siegal; S Kopel; J Leibovici
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

7.  T-lymphocyte subpopulations in multiple sclerosis--do they help to judge immunosuppressive therapy?

Authors:  A Henneberg; E G Fischer; H H Kornhuber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

8.  Mast cells display natural suppressor activity partially by releasing transforming growth factor-beta.

Authors:  Z Q Hu; T Yamazaki; Z Cai; T Yoshida; T Shimamura
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

Review 9.  Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma.

Authors:  Dawn Swan; Mark Gurney; Janusz Krawczyk; Aideen E Ryan; Michael O'Dwyer
Journal:  Hemasphere       Date:  2020-04-03

10.  The Monocytes That Repopulate in Mice After Cyclophosphamide Treatment Acquire a Neutrophil Precursor Gene Signature and Immunosuppressive Activity.

Authors:  Zhi-Chun Ding; Nada S Aboelella; Locke Bryan; Huidong Shi; Gang Zhou
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.